| 1 |
Guideline [Antiretroviral treatment guide for adult people living with HIV/AIDS] 2004
Soto-Ramírez LE, Pérez-Saleme L, Hernandez-Tepichin G, Sierra-Madero J, León-Juárez EA, Romo-García J, Rangel-Frausto S, Gaona-Flores V, Jáuregui-Chiu M, López-Martínez C, Vázquez-Valls E, Varela-Trejo C, Anonymous00286. · Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF. · Rev Invest Clin. · Pubmed #15377079 No free full text.
This publication has no abstract.
|
| 2 |
Article Anti-chlamydophila pneumoniae antibodies as associated factor for carotid atherosclerosis in patients with AIDS. 2008
Gaona-Flores V, García-Elorriaga G, Valerio-Minero M, González-Veyrand E, Navarrete-Castro R, Palacios-Jiménez N, Del Rey-Pineda G, González-Bonilla C, Monasta L. · Hospital de Infectologìa Centro Médico Nacional La Raza, CMNR. México. · Curr HIV Res. · Pubmed #18473791 No free full text.
Abstract: Atherosclerosis is a multifactor disease. Lately, infectious factors such as C. pneumoniae have been found to be involved. To determine whether the infection by C. pneumoniae is a risk factor for atherosclerosis in patients with AIDS. Case-control study on 43 patients with AIDS under HAART (16 cases and 27 controls). To document atherosclerosis, a carotid and transcranial Doppler ultrasound was performed. Anti-C pneumoniae antibodies were searched using a microimmunofluorescence test for IgM and IgG levels. To study the associations with risk of atherosclerosis, Odds Ratios were calculated for each IgG anti-C. pneumoniae antibody titre. A titre of 1:64 significantly increased the risk of atherosclerosis. These results suggest that hypertriglyceridemia and C. pneumoniae infection coexistence significantly increases the risk of atherosclerosis. The inverse geometric average of the antibodies titre against C. pneumoniae in individuals with atheromatous plaque fell to 64, two titres above the controls. This difference turned out to be statistically significant. Exposure to C. pneumoniae with antibodies (IgG) should be considered in any HIV diagnosed patient as a risk factor for atherosclerosis, having found that the inverse geometric averages of antibodies titre are significantly different comparing cases and controls, especially in patients with dyslipidemia, hypertriglyceridemia or in patients whose treatments could cause these conditions. In patients with concomitant hypertriglyceridemia, the association increases up to three times. It is advisable that AIDS patients take a serological test to determine exposure to C. pneumoniae, and to assess treatment options.
|